Oral nanomedicine biointeractions in the gastrointestinal tract in health and disease.
(2023) Advanced Drug Delivery Reviews — Vol. 203, p. 115117 (2023)
Files
RevisedADDRreview-02102023.docx
Open Access - Microsoft Word XML
- 4.92 MB
Details
- Authors
- Abstract
- Oral administration is the preferred route of administration based on the convenience for and compliance of the patient. Oral nanomedicines have been developed to overcome the limitations of free drugs and overcome gastrointestinal (GI) barriers, which are heterogeneous across healthy and diseased populations. This review aims to provide a comprehensive overview and comparison of the oral nanomedicine biointeractions in the gastrointestinal tract (GIT) in health and disease (GI and extra-GI diseases) and highlight emerging strategies that exploit these differences for oral nanomedicine-based treatment. We introduce the key GI barriers related to oral delivery and summarize their pathological changes in various diseases. We discuss nanomedicine biointeractions in the GIT in health by describing the general biointeractions based on the type of oral nanomedicine and advanced biointeractions facilitated by advanced strategies applied in this field. We then discuss nanomedicine biointeractions in different diseases and explore how pathological characteristics have been harnessed to advance the development of oral nanomedicine.
- Affiliations
Citations
Chen, C., Beloqui Garcia, A., & Xu, Y. (2023). Oral nanomedicine biointeractions in the gastrointestinal tract in health and disease. Advanced Drug Delivery Reviews, 203, 115117. https://doi.org/10.1016/j.addr.2023.115117 (Original work published 2023)